ADC Therapeutics Cancels Nasdaq IPO Amidst Market Growth Fears
The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO,…
The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO,…
The Swedish biotech Aprea Therapeutics has entered a new collaboration with the Memorial Sloan Kettering…
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…
Aprea raised a huge €46M for a first-in-class drug that targets the deadliest form of ovarian cancer. The…
Pharma and Biotech from every corner flocked to Chicago for the beginning of June. Why?…
BIO-Europe Spring 2016 is starting off right away with the plenary opening session. The conference…
Aprea (Sweden) is not a well-know Biotech (yet), but has succeeded in raising €46M from…